First Trust Advisors’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
|
|||||
|
2025
Q1 | $25.2M | Buy |
|
|||||
|
2024
Q4 | $37.9M | Sell |
|
|||||
|
2024
Q3 | $58.1M | Buy |
|
|||||
|
2024
Q2 | $16.1M | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $41.7M | Buy |
|
|||||
|
2023
Q3 | $52.2M | Sell |
|
|||||
|
2023
Q2 | $69.2M | Sell |
|
|||||
|
2023
Q1 | $95M | Sell |
|
|||||
|
2022
Q4 | $91.7M | Sell |
|
|||||
|
2022
Q3 | $101M | Buy |
|
|||||
|
2022
Q2 | $51.7M | Sell |
|
|||||
|
2022
Q1 | $67.2M | Sell |
|
|||||
|
2021
Q4 | $81M | Sell |
|
|||||
|
2021
Q3 | $85.9M | Buy |
|
|||||
|
2021
Q2 | $67.8M | Sell |
|
|||||
|
2021
Q1 | $66M | Buy |
|
|||||
|
2020
Q4 | $91.5M | Sell |
|
|||||
|
2020
Q3 | $82.5M | Sell |
|
|||||
|
2020
Q2 | $107M | Buy |
|
|||||
|
2020
Q1 | $51.9M | Sell |
|
|||||
|
2019
Q4 | $77.3M | Sell |
|
|||||
|
2019
Q3 | $50.4M | Sell |
|
|||||
|
2019
Q2 | $133M | Buy |
|
|||||
|
2019
Q1 | $11.7M | Sell |
|
|||||
|
2018
Q4 | $41M | Buy |
|
|||||
|
2018
Q3 | $38.3M | Buy |
|
|||||
|
2018
Q2 | $8.41M | Buy |
|
|||||
|
2018
Q1 | $3.85M | Buy |
|
|||||
|
2017
Q4 | $2.38M | Sell |
|
|||||
|
2017
Q3 | $2.62M | Buy |
|
|||||
|
2017
Q2 | $1.05M | Buy |
|
|||||
|
2017
Q1 | $526K | Sell |
|
|||||
|
2016
Q4 | $780K | Buy |
|